Commonwealth Equity Services LLC Trims Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Commonwealth Equity Services LLC reduced its stake in Teladoc Health, Inc. (NYSE:TDOC – Get Rating) by 21.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 93,799 shares of the health services provider’s stock after selling 25,279 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Teladoc Health were worth $2,218,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in TDOC. MetLife Investment Management LLC purchased a new stake in shares of Teladoc Health in the first quarter valued at $218,000. Panagora Asset Management Inc. lifted its position in shares of Teladoc Health by 18.8% in the first quarter. Panagora Asset Management Inc. now owns 16,710 shares of the health services provider’s stock valued at $1,205,000 after acquiring an additional 2,640 shares in the last quarter. Rhumbline Advisers lifted its position in shares of Teladoc Health by 2.3% in the first quarter. Rhumbline Advisers now owns 130,916 shares of the health services provider’s stock valued at $9,443,000 after acquiring an additional 2,921 shares in the last quarter. Great West Life Assurance Co. Can lifted its position in Teladoc Health by 10.8% during the first quarter. Great West Life Assurance Co. Can now owns 107,908 shares of the health services provider’s stock worth $8,237,000 after buying an additional 10,559 shares during the period. Finally, Raymond James Trust N.A. lifted its position in Teladoc Health by 7.8% during the first quarter. Raymond James Trust N.A. now owns 11,451 shares of the health services provider’s stock worth $826,000 after buying an additional 827 shares during the period. 84.14% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Trading Down 3.4 %

TDOC stock opened at $23.91 on Wednesday. The company has a current ratio of 3.37, a quick ratio of 3.25 and a debt-to-equity ratio of 0.67. Teladoc Health, Inc. has a 1 year low of $21.60 and a 1 year high of $44.66. The stock has a 50-day simple moving average of $25.56 and a 200-day simple moving average of $26.83.

Teladoc Health (NYSE:TDOC – Get Rating) last posted its earnings results on Wednesday, April 26th. The health services provider reported ($0.37) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.51) by $0.14. Teladoc Health had a negative return on equity of 5.81% and a negative net margin of 285.51%. The business had revenue of $629.24 million during the quarter, compared to analyst estimates of $617.55 million. Sell-side analysts forecast that Teladoc Health, Inc. will post -1.38 EPS for the current year.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, SVP Daniel Trencher sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, February 17th. The stock was sold at an average price of $30.21, for a total transaction of $30,210.00. Following the completion of the sale, the senior vice president now owns 20,408 shares in the company, valued at approximately $616,525.68. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Teladoc Health news, SVP Andrew Turitz sold 1,801 shares of the firm’s stock in a transaction that occurred on Thursday, March 2nd. The stock was sold at an average price of $25.36, for a total transaction of $45,673.36. Following the completion of the sale, the senior vice president now owns 18,382 shares in the company, valued at approximately $466,167.52. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Daniel Trencher sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, February 17th. The shares were sold at an average price of $30.21, for a total value of $30,210.00. Following the sale, the senior vice president now owns 20,408 shares of the company’s stock, valued at approximately $616,525.68. The disclosure for this sale can be found here. Insiders sold a total of 58,423 shares of company stock worth $1,521,260 in the last 90 days. 1.63% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on TDOC shares. Canaccord Genuity Group reduced their target price on Teladoc Health from $40.00 to $36.00 and set a “buy” rating on the stock in a research report on Monday, March 6th. Barclays increased their target price on Teladoc Health from $28.00 to $29.00 in a research report on Thursday, April 27th. Stephens started coverage on Teladoc Health in a research report on Tuesday, April 11th. They set an “equal weight” rating and a $25.00 target price on the stock. 888 reiterated a “maintains” rating on shares of Teladoc Health in a research report on Friday, April 28th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $35.00 target price on shares of Teladoc Health in a research report on Thursday, February 23rd. One analyst has rated the stock with a sell rating, seventeen have given a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, Teladoc Health has a consensus rating of “Hold” and an average price target of $32.78.

Teladoc Health Company Profile

(Get Rating)

Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services.